Cargando…

Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease

In the context of respiratory disease, chronic obstructive pulmonary disease (COPD) is the leading cause of mortality worldwide. Despite much development in the area of drug development, currently there are no effective medicines available for the treatment of this disease. An imbalance in the prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dey, Tapan, Kalita, Jatin, Weldon, Sinéad, Taggart, Clifford C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162857/ https://www.ncbi.nlm.nih.gov/pubmed/30154365 http://dx.doi.org/10.3390/jcm7090244

Ejemplares similares

Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease
por: McKelvey, Michael C., et al.
Publicado: (2021)

The Serpin-tine Search for Factors Associated with COVID-19 Severity in Patients with Chronic Obstructive Pulmonary Disease
por: Scott, Aaron, et al.
Publicado: (2022)

The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
por: Twigg, Matthew S., et al.
Publicado: (2015)

The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
por: McGarry, Niamh, et al.
Publicado: (2015)

The Impact of Lung Proteases on Snake-Derived Antimicrobial Peptides
por: Creane, Shannice E., et al.
Publicado: (2021)

Therapeutic potentials of Houttuynia cordata Thunb. against inflammation and oxidative stress: A review
por: Shingnaisui, Khanchuila, et al.
Publicado: (2018)

Role of Proteases in Chronic Obstructive Pulmonary Disease
por: Pandey, Kailash C., et al.
Publicado: (2017)

Type I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors
por: Foronjy, Robert F., et al.
Publicado: (2014)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

Antioxidant Potential of Vespa affinis L., a Traditional Edible Insect Species of North East India
por: Dutta, Prachurjya, et al.
Publicado: (2016)

Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium
por: Guo-Parke, Hong, et al.
Publicado: (2022)

Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation
por: Guo-Parke, Hong, et al.
Publicado: (2020)

Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2020)

Fasciola hepatica-Derived Molecules as Regulators of the Host Immune Response
por: Ryan, Sinéad, et al.
Publicado: (2020)

Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics
por: Brown, Ryan, et al.
Publicado: (2020)

Pulmonary embolism with chronic obstructive pulmonary disease
por: Yang, Ruohan, et al.
Publicado: (2021)

Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway
por: Kumar, Manish, et al.
Publicado: (2013)

Respiratory Syncytial Virus Infections Enhance Cigarette Smoke Induced COPD in Mice
por: Foronjy, Robert F., et al.
Publicado: (2014)

The genetics of chronic obstructive pulmonary disease
por: Wood, Alice M, et al.
Publicado: (2006)

Models of chronic obstructive pulmonary disease
por: Groneberg, David A, et al.
Publicado: (2004)

Genetics of chronic obstructive pulmonary disease
por: Seifart, Carola, et al.
Publicado: (2007)

The genetics of chronic obstructive pulmonary disease
por: Lomas, David A, et al.
Publicado: (2001)

Osteoporosis in Chronic Obstructive Pulmonary Disease
por: Sarkar, Malay, et al.
Publicado: (2015)

Telemedicine in chronic obstructive pulmonary disease
por: Ambrosino, Nicolino, et al.
Publicado: (2016)

Hyperglycaemia and Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2023)

Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis
por: Bateman, Georgia, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease
por: Vijayan, V.K.
Publicado: (2013)

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics
por: Ahmadi, Ali, et al.
Publicado: (2023)

Eosinophilic Chronic Obstructive Pulmonary Disease
por: Weissler, Jonathan C., et al.
Publicado: (2021)

Balance impairment and cognitive dysfunction in patients with chronic obstructive pulmonary disease under 65 years
por: Kaygusuz, Melike Hanim, et al.
Publicado: (2022)

Role of Environmental Pollutants in Liver Physiology: Special References to Peoples Living in the Oil Drilling Sites of Assam
por: Dey, Tapan, et al.
Publicado: (2015)

What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?
por: Gualano, Rosa C., et al.
Publicado: (2006)

Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease
por: Parameswaran, Ganapathi I, et al.
Publicado: (2009)

Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Restrepo, Marcos I., et al.
Publicado: (2018)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease
por: Thorley, Andrew J, et al.
Publicado: (2007)

Mechanisms of atherothrombosis in chronic obstructive pulmonary disease
por: Fimognari, Filippo Luca, et al.
Publicado: (2008)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Pharmacological treatment of chronic obstructive pulmonary disease
por: Montuschi, Paolo
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_kq5l7p03t9oj4j5tu370lkcma5